Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

Despite a strong correlation between telomerase activity and malignancy, the outcome of telomerase inhibition in human tumor cells has not been examined. Here, we have addressed the role of telomerase activity in the proliferation of human tumor and immortal cells by inhibiting TERT function. Inducible dominant-negative mutants of hTERT dramatically reduced the level of endogenous telomerase activity in tumor cell lines. Clones with short telomeres continued to divide, then exhibited an increase in abnormal mitoses followed by massive apoptosis leading to the loss of the entire population. This cell death was telomere-length dependent, as cells with long telomeres were viable but exhibited telomere shortening at a rate similar to that of mortal cells. It appears that telomerase inhibition in cells with short telomeres lead to chromosomal damage, which in turn trigger apoptotic cell death. These results provide the first direct evidence that telomerase is required for the maintenance of human tumor and immortal cell viability, and suggest that tumors with short telomeres may be effectively and rapidly killed following telomerase inhibition.

[1]  L. Chin,et al.  Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse , 1999, Cell.

[2]  Lynda Chin,et al.  p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.

[3]  D. Broccoli,et al.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. , 1999, Science.

[4]  K. Collins,et al.  The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Cech,et al.  Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Barnett,et al.  Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  R. Silverman,et al.  Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA , 1998, Oncogene.

[8]  H. Niida,et al.  Severe growth defect in mouse cells lacking the telomerase RNA component , 1998, Nature Genetics.

[9]  Yoshikazu Tanaka,et al.  Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis , 1998, Oncogene.

[10]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[11]  L. Chin,et al.  Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation , 1998, Oncogene.

[12]  C. Greider.  Telomeres and senescence: The history, the experiment, the future , 1998, Current Biology.

[13]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[14]  M. Robinson,et al.  Reconstitution of human telomerase activity in vitro , 1998, Current Biology.

[15]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[16]  F. Ishikawa,et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas , 1998, Nature Genetics.

[17]  M. Bass,et al.  Human telomerase contains evolutionarily conserved catalytic and structural subunits. , 1997, Genes & development.

[18]  V. Lundblad.  The end replication problem: More than one solution , 1997, Nature Medicine.

[19]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[20]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[21]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[22]  R. Weinberg,et al.  The catalytic subunit of yeast telomerase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T R Hughes,et al.  Reverse transcriptase motifs in the catalytic subunit of telomerase. , 1997, Science.

[24]  R. Reddel,et al.  Telomere dynamics and telomerase activity in in vitro immortalised human cells. , 1997, European journal of cancer.

[25]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[26]  A. Matsuura,et al.  TLP1: A Gene Encoding a Protein Component of Mammalian Telomerase Is a Novel Member of WD Repeats Family , 1997, Cell.

[27]  Lea Harrington,et al.  A Mammalian Telomerase-Associated Protein , 1997, Science.

[28]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[29]  Harley Cb,et al.  Telomerase, checkpoints and cancer. , 1997 .

[30]  C. Harley,et al.  Telomerase, checkpoints and cancer. , 1997, Cancer surveys.

[31]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[32]  T. Lendvay,et al.  Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. , 1996, Genetics.

[33]  C. Greider,et al.  Telomere length regulation. , 1996, Annual review of biochemistry.

[34]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[35]  R. Kobayashi,et al.  Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme , 1995, Cell.

[36]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[37]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[38]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[39]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[40]  J. Szostak,et al.  A mutant with a defect in telomere elongation leads to senescence in yeast , 1989, Cell.

[41]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[42]  This article cites 117 articles, 43 of which can be accessed free at: , 2022 .